FindTrial
Sign In

The clinical role of vascular endothelial growth factor A in the pulmonary metastasis of nasopharyngeal carcinoma

The clinical role of vascular endothelial growth factor A in the pulmonary metastasis of nasopharyngeal carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17012336
Enrollment
Unknown
Registered
2017-08-11
Start date
2017-08-15
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nasopharyngeal carcinoma

Interventions

Gold Standard:Pathological examination
Index test:Immunohistochemistry

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) diagnosed with nasopharyngeal carcinoma by pathological examination; (2) patients with age over eighteen years old; (3) patients with good Karnofsky Performance Status (KPS) of more than 80; (4) exclusion of immunodeficiency and other serious disease.

Exclusion criteria

Exclusion criteria: with immunodeficiency and other serious disease

Design outcomes

Primary

MeasureTime frame
VEGFA;—

Countries

China

Contacts

Public ContactLiao Zhi-Su

The First Affiliated Hospital of Wenzhou Medical University

liaozhisu111@163.com+86 13600671002

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026